ID27024A - Faktor pertumbuhan neurotrofi - Google Patents

Faktor pertumbuhan neurotrofi

Info

Publication number: ID27024A
Authority: ID; Indonesia
Prior art keywords: growth factor; neurotrofi; growth factors; bioprecursor; organism
Prior art date: 1998-07-14

Application number

IDW20010091A

Other languages

English (en)

Indonesian (id)

Inventor

H A G Geerts

S L J Masure

T F Meert

Miraslov Cik

Luc Ver Donck

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-14

Filing date

1999-07-14

Publication date

2001-02-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27024(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-07-14 Priority claimed from GBGB9815283.8A external-priority patent/GB9815283D0/en

1999-07-14 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2001-02-22 Publication of ID27024A publication Critical patent/ID27024A/id

Links

239000003102 growth factor Substances 0.000 title abstract 4
102100026376 Artemin Human genes 0.000 abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 2
108010059258 enovin Proteins 0.000 abstract 2
150000007523 nucleic acids Chemical class 0.000 abstract 2
102000039446 nucleic acids Human genes 0.000 abstract 2
108020004707 nucleic acids Proteins 0.000 abstract 2
230000000508 neurotrophic effect Effects 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Zoology (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Hospice & Palliative Care (AREA)
Pathology (AREA)
Cell Biology (AREA)
Pain & Pain Management (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Psychology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)

IDW20010091A 1998-07-14 1999-07-14 Faktor pertumbuhan neurotrofi ID27024A (id)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9815283.8A GB9815283D0 (en)	1998-07-14	1998-07-14	Neurotrophic growth factor
US24877299A	1999-02-12	1999-02-12
US32766899A	1999-06-08	1999-06-08

Publications (1)

Publication Number	Publication Date
ID27024A true ID27024A (id)	2001-02-22

Family

ID=27269394

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010091A ID27024A (id)	1998-07-14	1999-07-14	Faktor pertumbuhan neurotrofi

Country Status (28)

Country	Link
US (1)	US7544788B2 (cs)
EP (2)	EP1640381B1 (cs)
JP (2)	JP4469500B2 (cs)
KR (2)	KR100773776B1 (cs)
CN (1)	CN1243770C (cs)
AT (1)	ATE343594T1 (cs)
AU (1)	AU768472B2 (cs)
BG (1)	BG65518B1 (cs)
BR (2)	BRPI9912819B8 (cs)
CA (1)	CA2333910C (cs)
CY (2)	CY1105949T1 (cs)
CZ (1)	CZ303868B6 (cs)
DE (1)	DE69933771T2 (cs)
DK (2)	DK1097167T3 (cs)
ES (2)	ES2479067T3 (cs)
HK (1)	HK1045528B (cs)
HR (1)	HRP20010036B1 (cs)
HU (1)	HU226073B1 (cs)
ID (1)	ID27024A (cs)
IL (1)	IL140877A0 (cs)
NO (1)	NO331809B1 (cs)
NZ (1)	NZ509723A (cs)
PL (1)	PL209952B1 (cs)
PT (2)	PT1640381E (cs)
SI (1)	SI1640381T1 (cs)
SK (1)	SK287361B6 (cs)
TR (1)	TR200100074T2 (cs)
WO (1)	WO2000004050A2 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6593133B1 (en)	1998-07-06	2003-07-15	Nsgene A/S	Neurotrophic factors
BR9911908A (pt) *	1998-07-06	2001-03-27	Nsgene As	ácido nucléico, sequência de ácido nucléico, processos de usar um ácido nucléico, de usar o vetor, de fabricar o polipeptìdeo, de administrar o polipeptìdeo, de tratar uma doença ou distúrbio neurodegenerativos em um animal, de determinar se uma doença ou distúrbio neurodegenerativos em um animal, de produzir qualquer um polipeptìdeo, processo para identificar, isolar ou amplificar uma sequência de ácido nucléico de neublastina, de diagnosticar ou avaliar quanto a presença de uma doença ou distúrbio ou uma predisposiçãopara desnvolvê-los, para avaliar um polipeptìdeo de neublastina purificado ou um derivado ou fragmento deste ou um modulador da atividade dos precedentes quanto a atividade em tratar ou prevenir uma doença, de tratar um distúbio neurológico, de usar a sequência de um ou mais ácidos nucléicos, e para identificar um composto candidato que induza um efeito biológico mediado pela neuroblastina, vetor, célula transformada com ácido nucléico, polipeptìdeo, cmposição, anticorpo, gene sintético, e, conjunto.
US7067473B1 (en) *	1998-07-14	2006-06-27	Janssen Pharmaceutica N.V.	Neurotrophic growth factor
DE69933771T2 (de) *	1998-07-14	2007-09-13	Janssen Pharmaceutica N.V.	Neurotrophischer wachstumsfaktor
US20020002269A1 (en) *	1998-09-29	2002-01-03	Jeffrey D. Milbrandt	Artemin, a neurotrophic factor
WO2000034475A2 (en) *	1998-12-09	2000-06-15	Amgen Inc.	Grnf4, a gdnf-related neurotrophic factor
EP1873244A3 (en) *	1999-06-02	2008-04-02	Genentech, Inc.	Methods and compositions for inhibiting neoplastic cell growth
IL156559A0 (en) *	2000-12-22	2004-01-04	Genentech Inc	New use of artemin, a member of the gdnf ligand family
US7442370B2 (en)	2001-02-01	2008-10-28	Biogen Idec Ma Inc.	Polymer conjugates of mutated neublastin
US7276580B2 (en) *	2001-03-12	2007-10-02	Biogen Idec Ma Inc.	Neurotrophic factors
ES2374971T3 (es) *	2001-03-28	2012-02-23	Biogen Idec Ma Inc.	Uso de polipéptidos de neublastina para el tratamiento del dolor neuropático.
US20040077543A1 (en) *	2001-03-28	2004-04-22	Sah Dinah W. Y.	Treatment using neublastin polypeptides
CN100411618C (zh) *	2002-05-17	2008-08-20	迪欧加药品公司	有效的选择性阿片受体调制剂化合物的用途
JP4571776B2 (ja) *	2002-11-05	2010-10-27	Ｊｘ日鉱日石エネルギー株式会社	潤滑油組成物
WO2004094592A2 (en)	2003-04-18	2004-11-04	Biogen Idec Ma Inc.	Polymer-conjugated glycosylated neublastin
ATE423134T1 (de)	2003-06-10	2009-03-15	Nsgene As	Verbesserte sezernierung von neublastin
US7598059B2 (en)	2003-10-02	2009-10-06	Biogen Idec Ma Inc.	Neublastin expression constructs
KR101241551B1 (ko) *	2004-08-19	2013-03-11	바이오겐 아이덱 엠에이 인코포레이티드	전환 성장 인자 베타 패밀리 단백질의 리폴딩
KR101215697B1 (ko) *	2004-08-19	2012-12-28	바이오겐 아이덱 엠에이 인코포레이티드	뉴블라스틴 변형체
TWI501774B (zh)	2006-02-27	2015-10-01	Biogen Idec Inc	神經性病症之治療
ES2450065T3 (es) *	2006-03-01	2014-03-21	Biogen Idec Ma Inc.	Composiciones y métodos para la administración de proteínas de la familia de ligandos del GDNF
CA2677273A1 (en)	2007-02-06	2008-08-14	Tai-June Yoo	Use of a composition comprising a cytokine encoding nucleic acid for treating alzheimer's disease
ES2476253T3 (es)	2007-05-01	2014-07-14	Biogen Idec Ma Inc.	P�ptidos de neublastina para su uso en el aumento de la vascularizaci�n en tejido con flujo sanguíneo deteriorado
AU2008269689A1 (en) *	2007-06-27	2008-12-31	Auckland Uniservices Limited	Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
WO2009020964A2 (en) *	2007-08-08	2009-02-12	Biogen Idec Ma Inc.	Anti-neublastin antibodies and uses thereof
JO3462B1 (ar) *	2012-08-22	2020-07-05	Regeneron Pharma	أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها
US11225689B2 (en) *	2016-08-17	2022-01-18	The Broad Institute, Inc.	Method for determination and identification of cell signatures and cell markers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5194596A (en)	1989-07-27	1993-03-16	California Biotechnology Inc.	Production of vascular endothelial cell growth factor
US5350836A (en)	1989-10-12	1994-09-27	Ohio University	Growth hormone antagonists
US5739307A (en)	1995-08-28	1998-04-14	Washington University	Polynucleotide encoding neurturin neurotrophic factor
US5972338A (en)	1997-09-19	1999-10-26	Genentech, Inc.	Tie ligands homologues
US6593133B1 (en) *	1998-07-06	2003-07-15	Nsgene A/S	Neurotrophic factors
US20020055467A1 (en) *	1998-07-06	2002-05-09	Johansen Teit E.	Novel neurotrophic factors
DE69933771T2 (de) *	1998-07-14	2007-09-13	Janssen Pharmaceutica N.V.	Neurotrophischer wachstumsfaktor
US7067473B1 (en)	1998-07-14	2006-06-27	Janssen Pharmaceutica N.V.	Neurotrophic growth factor
US20020002269A1 (en)	1998-09-29	2002-01-03	Jeffrey D. Milbrandt	Artemin, a neurotrophic factor
WO2000034475A2 (en) †	1998-12-09	2000-06-15	Amgen Inc.	Grnf4, a gdnf-related neurotrophic factor
JP2002051906A (ja) *	2000-08-11	2002-02-19	Nippon Platec Co Ltd	Ｉｈ調理器による加熱を可能にしたアルミ箔材料及びこのアルミ箔材料を用いて成形したアルミ箔材料製食品用容器
US7276580B2 (en) *	2001-03-12	2007-10-02	Biogen Idec Ma Inc.	Neurotrophic factors
WO2018191688A2 (en) †	2017-04-14	2018-10-18	Johnson Controls Techology Company	Thermostat with exhaust fan control for air quality and humidity control

1999
- 1999-07-14 DE DE69933771T patent/DE69933771T2/de not_active Expired - Lifetime
- 1999-07-14 CA CA2333910A patent/CA2333910C/en not_active Expired - Lifetime
- 1999-07-14 JP JP2000560156A patent/JP4469500B2/ja not_active Expired - Lifetime
- 1999-07-14 KR KR1020067009858A patent/KR100773776B1/ko not_active Expired - Lifetime
- 1999-07-14 TR TR2001/00074T patent/TR200100074T2/xx unknown
- 1999-07-14 HK HK02106928.2A patent/HK1045528B/zh not_active IP Right Cessation
- 1999-07-14 SI SI9931076T patent/SI1640381T1/sl unknown
- 1999-07-14 NZ NZ509723A patent/NZ509723A/en not_active IP Right Cessation
- 1999-07-14 SK SK14-2001A patent/SK287361B6/sk not_active IP Right Cessation
- 1999-07-14 EP EP05112473.3A patent/EP1640381B1/en not_active Expired - Lifetime
- 1999-07-14 DK DK99938261T patent/DK1097167T3/da active
- 1999-07-14 HU HU0102821A patent/HU226073B1/hu unknown
- 1999-07-14 DK DK05112473.3T patent/DK1640381T3/da active
- 1999-07-14 IL IL14087799A patent/IL140877A0/xx not_active IP Right Cessation
- 1999-07-14 ID IDW20010091A patent/ID27024A/id unknown
- 1999-07-14 KR KR1020017000494A patent/KR100712223B1/ko not_active Expired - Lifetime
- 1999-07-14 ES ES05112473.3T patent/ES2479067T3/es not_active Expired - Lifetime
- 1999-07-14 AT AT99938261T patent/ATE343594T1/de active
- 1999-07-14 CN CNB998108847A patent/CN1243770C/zh not_active Expired - Lifetime
- 1999-07-14 PL PL348431A patent/PL209952B1/pl unknown
- 1999-07-14 ES ES99938261T patent/ES2275349T3/es not_active Expired - Lifetime
- 1999-07-14 HR HR20010036A patent/HRP20010036B1/xx not_active IP Right Cessation
- 1999-07-14 CZ CZ20010028A patent/CZ303868B6/cs not_active IP Right Cessation
- 1999-07-14 PT PT51124733T patent/PT1640381E/pt unknown
- 1999-07-14 AU AU52832/99A patent/AU768472B2/en not_active Expired
- 1999-07-14 WO PCT/EP1999/005031 patent/WO2000004050A2/en not_active Ceased
- 1999-07-14 PT PT99938261T patent/PT1097167E/pt unknown
- 1999-07-14 EP EP99938261.7A patent/EP1097167B2/en not_active Expired - Lifetime
- 1999-07-14 BR BRPI9912819A patent/BRPI9912819B8/pt unknown
- 1999-07-14 BR BR9912819-5A patent/BR9912819A/pt not_active IP Right Cessation
2001
- 2001-01-03 BG BG105107A patent/BG65518B1/bg unknown
- 2001-01-12 NO NO20010212A patent/NO331809B1/no not_active IP Right Cessation
2005
- 2005-03-08 US US11/074,498 patent/US7544788B2/en not_active Expired - Fee Related
2007
- 2007-01-25 CY CY20071100092T patent/CY1105949T1/el unknown
2010
- 2010-01-14 JP JP2010006098A patent/JP4624476B2/ja not_active Expired - Lifetime
2014
- 2014-07-16 CY CY20141100535T patent/CY1115496T1/el unknown

Also Published As

Publication number	Publication date
IL140877A0 (en)	2002-02-10
TR200100074T2 (tr)	2001-11-21
JP2010158241A (ja)	2010-07-22
AU768472B2 (en)	2003-12-11
EP1640381B1 (en)	2014-05-14
CN1243770C (zh)	2006-03-01
JP2002520042A (ja)	2002-07-09
NO20010212L (no)	2001-03-14
HK1092477A1 (en)	2007-02-09
EP1097167B1 (en)	2006-10-25
HUP0102821A3 (en)	2003-09-29
NO331809B1 (no)	2012-04-10
CA2333910A1 (en)	2000-01-27
EP1097167B2 (en)	2018-12-12
DK1097167T3 (da)	2007-03-12
WO2000004050A3 (en)	2000-11-09
SK142001A3 (en)	2002-02-05
PT1640381E (pt)	2014-07-17
HK1045528A1 (en)	2002-11-29
BRPI9912819B1 (pt)	2018-09-18
ATE343594T1 (de)	2006-11-15
PL209952B1 (pl)	2011-11-30
HRP20010036A2 (en)	2001-12-31
HRP20010036B1 (hr)	2010-06-30
BG105107A (en)	2001-10-31
BR9912819A (pt)	2001-05-02
ES2479067T3 (es)	2014-07-23
HU226073B1 (en)	2008-04-28
NO20010212D0 (no)	2001-01-12
EP1097167A2 (en)	2001-05-09
CZ200128A3 (cs)	2001-08-15
JP4624476B2 (ja)	2011-02-02
CY1105949T1 (el)	2011-04-06
HK1045528B (zh)	2006-10-27
SI1640381T1 (sl)	2014-07-31
CA2333910C (en)	2016-11-15
KR20060061408A (ko)	2006-06-07
EP1640381A3 (en)	2007-01-31
AU5283299A (en)	2000-02-07
DE69933771D1 (de)	2006-12-07
DK1640381T3 (da)	2014-07-14
KR100712223B1 (ko)	2007-04-27
PL348431A1 (en)	2002-05-20
ES2275349T3 (es)	2007-06-01
KR20010083108A (ko)	2001-08-31
BG65518B1 (bg)	2008-10-31
BRPI9912819B8 (pt)	2021-05-25
WO2000004050A2 (en)	2000-01-27
EP1640381A2 (en)	2006-03-29
DE69933771T2 (de)	2007-09-13
HUP0102821A2 (hu)	2001-11-28
KR100773776B1 (ko)	2007-11-12
CZ303868B6 (cs)	2013-06-05
US7544788B2 (en)	2009-06-09
US20050233359A1 (en)	2005-10-20
JP4469500B2 (ja)	2010-05-26
SK287361B6 (sk)	2010-08-09
CY1115496T1 (el)	2017-01-04
NZ509723A (en)	2004-01-30
PT1097167E (pt)	2007-02-28
CN1342165A (zh)	2002-03-27

Publication	Publication Date	Title
DK1097167T3 (da)	2007-03-12	Neurotrofisk vækstfaktor
EP2298355A3 (en)	2011-06-29	Albumin fusion proteins
DK0733067T3 (da)	1999-11-01	N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
AU6160201A (en)	2001-11-26	Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
NL300272I1 (nl)	2007-05-01	DNA dat humaan papillomavirus type 18 codeert.
DE69841160D1 (de)	2009-10-29	Aktivitätsabhänginger neurotropischer faktor iii(adnf iii)
DE69635472D1 (de)	2005-12-29	Impfstoff gegen Geflügelkokzidose
DE60126602D1 (de)	2007-03-29	Neue collectine
ATE348158T1 (de)	2007-01-15	Neuartiges collectin
ATE435277T1 (de)	2009-07-15	18477, eine menschliche proteinkinase und deren verwendung
DK0919621T3 (da)	2009-01-19	Human TAK1 og DNA der koder derfor
WO2000000506A3 (en)	2000-04-20	Human proteins having hydrophobic domains and dnas encoding these proteins
DE69534738D1 (de)	2006-04-06	Leukocyten-aktivierender Faktor
WO2001036458A3 (en)	2002-01-10	Drosophila ced-6 homologue
ATE202786T1 (de)	2001-07-15	Zellwachstum hemmendes protein
WO2002046380A3 (en)	2003-02-06	Protein kinase